Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Net Income (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Net Income for 2 consecutive years, with -$32.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income fell 58.99% to -$32.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was -$123.2 million, a 86.33% decrease, with the full-year FY2025 number at -$105.6 million, down 40.04% from a year prior.
  • Net Income was -$32.8 million for Q4 2025 at Kestra Medical Technologies, down from -$25.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$3.6 million in Q2 2024 to a low of -$42.8 million in Q2 2025.